grifols

European economy 7th May 2025

German stock market supervisor approves Grifols’ takeover bid for subsidiary Biotest at €43 per share

Link Securities | Grifols (GRF) informed the National Securities Market Commission (CNMV) that on Tuesday the German federal financial supervisory authority, the Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin), approved the publication of the offer document submitted by its subsidiary Grifols Biotest Holdings GmbH with the terms and conditions of the public takeover bid for delisting launched to all shareholders of Biotest AG to acquire all ordinary shares of Biotest, of which Grifols…

Spanish economy 11th April 2025

Brandes Investment increases stake in Grifols’ B shares to 16.4%

Alphavalue/DIVACONS | Brandes Investment Partners has taken advantage of the sharp fall in the stock market value of the Catalan company specialising in plasma products following the tariff crisis to increase its stake in the B shares (non-voting) to 16.4%, with an estimated value of €250 million. This position could be key if Brookfield decides to resume its takeover bid for the company. Grifols shares rose 6.63% on Thursday. Grifols:…

Relevant News Item 10th March 2025

Grifols loses over 5% after Securities Market Commission report slams financial management

CdM | Grifols shares lost more than 5% on the stock market on Monday. Last Friday, after the market had closed, a report was published by the National Securities Market Commission (CNMV) that was highly critical of the company’s financial management. According to the report sent by the CNMV to the investigating judge in the case, José Luis Calama, and to which “El Mundo” has had access, Grifols’ top management…

Spanish economy 17th February 2025

Capital Group, main shareholder in Grifols, reduces stake from 3.406% to 2.902% in order to consider exit

Link Securities | Capital Group, historical shareholder of Grifols, faces its exit by placing its stake in the company’s capital below 3%, Expansión newspaper reported yesterday. On 7 February, as recorded in the records of the National Securities Market Commission (CNMV), Capital Group reduced its stake in GRF to 2.902%, from the 3.406% declared on 5 February. Of the 2.9% declared by the fund, 0.45% is also on loan to…

In Spain 25th January 2025

Grifols brothers linked to investigation by CNMV into accusations by bearish fund Gotham City Research

Link Securities | Judge José Luis Calama of the National Court, who is investigating the Grifols case, has asked the National Securities Market Commission (CNMV) to send him a document supporting Gotham’s accusations, arguing that the Catalan pharmaceutical company omitted relevant data in its accounts and provided the market with inaccurate information, as reported yesterday by the digital newspaper ElConfidencial.com. The regulator’s report, which analyses the accusations of the bear…

In Spain 16th January 2025

Michael J. Fox Foundation donates Grifols $21 million to research new diagnostic tools for Parkinson’s disease

Link Securities | The Catalan blood products company has received a $21 million grant from the Michael J. Fox Foundation (MJFF) for Parkinson’s Disease Research to identify plasma-based biomarkers that could indicate a person’s likelihood of developing Parkinson’s disease (PD) “many years before” clinical diagnosis. The initiative, dubbed ‘Chronos PD’, could accelerate the discovery of new diagnostic tools, as well as the identification and development of novel therapies that modify…

In Spain 26th December 2024

Grifols completes bond issue earmarked for redemptions, settlements and corporate purposes

Link Securities | Grifols (GRF) informed the National Securities Market Commission (CNMV), in relation to a bond issue reported on 11 December that: the Bonds have been issued and the proceeds have been received and, therefore, the issue has been completed. The net proceeds of the issue have been used (i) together with cash on hand, to redeem in full on 27 December 2024 GRF’s 1.625% Senior Secured Notes due…

In Spain 13th December 2024

Grifols to issue €1.3 billion in bonds to refinance debt maturities in 2025

Bankinter: The company is to issue soon €1.3 billion in Guaranteed Bonds maturing in May 2023 with a coupon of 7.125%. Together with part of the cash (September: €644 million), it will be used to redeem close on €340 million of Senior Secured Bonds maturing in February 2025 with a coupon of 1.625% and to pay off the working capital loan facility maturing in November 2025. It also extends by…

In Spain 2nd December 2024

Grifols negotiates refinancing of bonds maturing next year and €1.4 billion credit line with banks

Link Securities | Grifols (GRF) is in negotiations with banks to refinance bonds maturing next year and a credit line, for a combined amount of €1.4 billion, as confirmed by the CEO of the pharmaceutical company, Nacho Abia, in an interview with Bloomberg reported by the digital portal Bolsamania.com. Abia explained that the company’s ‘plan A’ is to obtain a refinancing agreement for the €370 million in bonds maturing in…

Spanish economy 28th November 2024

Grifols plummets on stock market after Brookfield abandons €6.5 billion takeover bid

The Canadian fund Brookfield has decided to withdraw its interest in a public exclusion offer to acquire Grifols due to disagreements over the price with the board of directors of the Spanish pharmaceutical company, as previously reported by Bloomberg. “After conducting a thorough due diligence and considering the reactions of the Grifols Transaction Committee and the Grifols Board of Directors regarding the potential offer communicated to the market on November…

1 2 3 … 7 »